ET-01 in Subjects With Lateral Canthal Lines, LCL-210
Clinical trial NCT04985916 · COMPLETED
Trial details
- NCT number
- NCT04985916
- Sponsor
- Eirion Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2024-02-08
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.